title: Thrombocytosis associated with enoxaparin: A very rare cause in newborns.
abstract: Newborn infants are most vulnerable to the development of thrombosis because of the developing neonatal hemostatic system, perinatal risk factors and different types of medical conditions. Enoxaparin is the current anticoagulant of choice with advantages for the treatment of neonatal thrombosis. Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults. However, to our knowledge, in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin.
authors.affiliation: Fatih University School of Medicine, Department of Pediatrics, Division of Neonatology, Ankara, Turkey.
authors.forename: Alparslan
authors.initials: A
authors.lastname: Tonbul
authors.forename: Nurdan
authors.initials: N
authors.lastname: Uras
authors.forename: Cuneyt
authors.initials: C
authors.lastname: Tayman
authors.forename: Tugba
authors.initials: T
authors.lastname: Halici
authors.forename: Aziz
authors.initials: A
authors.lastname: Polat
authors.forename: Mustafa
authors.initials: M
authors.lastname: Mansur Tatli
mesh_terms: D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D017984:Enoxaparin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D011247:Pregnancy; D013922:Thrombocytosis / Q000139:chemically induced*; D013927:Thrombosis / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin